STAGE IVA CERVICAL CANCER AJCC V8
Clinical trials for STAGE IVA CERVICAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA CERVICAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA CERVICAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab. The goal is to see if the combination is safe and helps the immune system attack advanced solid tumors. About 132 people with various advanc…
Matched conditions: STAGE IVA CERVICAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental drug plus radiation shows promise for recurrent gynecologic cancers
Disease control Recruiting nowThis early-phase trial is testing the drug talazoparib together with radiation therapy in 24 women whose gynecologic cancer (ovarian, endometrial, cervical, or related cancers) has come back after previous treatment. Talazoparib blocks enzymes that cancer cells need to grow, and …
Matched conditions: STAGE IVA CERVICAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New registry aims to unlock secrets of rare cervical cancer
Knowledge-focused Recruiting nowThis study is creating a registry of 750 people with a rare and aggressive form of cervical cancer called neuroendocrine carcinoma. Researchers will collect information from medical records to learn more about the disease, how it is treated, and what happens to patients over time…
Matched conditions: STAGE IVA CERVICAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC